Oral contraceptive formulations
Synonyms / Brand Names:

# Dosing and Administration
Sunday Start
When taking ORTHO TRI-CYCLEN and ORTHO-CYCLEN the first tablet should be taken on the
first Sunday after menstruation begins. If period begins on Sunday, the first tablet should be taken that
day. Take one active tablet daily for 21 days followed by one green inactive tablet daily for 7 days.
After 28 tablets have been taken, a new course is started the next day (Sunday). For the first cycle of a
Sunday Start regimen, another method of contraception should be used until after the first 7
consecutive days of administration.
Day 1 Start
The dosage of ORTHO TRI-CYCLEN and ORTHO-CYCLEN , for the initial cycle of therapy is
-ne active tablet administered daily from the 1st day through the 21st day of the menstrual cycle,
counting the first day of menstrual flow as "Day 1" followed by one green inactive tablet daily for 7
days. Tablets are taken without interruption for 28 days. After 28 tablets have been taken, a new course
is started the next day.

## ACNE
The timing of initiation of dosing with ORTHO TRI-CYCLEN for acne should follow the guidelines
for use of ORTHO TRI-CYCLEN as an oral contraceptive. Consult the DOSAGE AND
ADMINISTRATION section for oral contraceptives. The dosage regimen for ORTHO TRICYCLEN
for treatment of facial acne, as available in a DIALPAK Tablet Dispenser, utilizes a 21-day
active and a 7-day placebo schedule. Take one active tablet daily for 21 days followed by one green
inactive tablet for 7 days. After 28 tablets have been taken, a new course is started the next day.
For more information on dosing please refer to Instructions for administration
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
 Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Espanol

# FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Oral contraceptive formulations
Return to top

# Publication Resources
Most Recent Articles on Oral contraceptive formulations
Review Articles on Oral contraceptive formulations
Articles on Oral contraceptive formulations in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Oral contraceptive formulations
Return to top

# Trial Resources
Ongoing Trials with Oral contraceptive formulations at Clinical Trials.gov
Trial Results with Oral contraceptive formulations
Return to top

# Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Oral contraceptive formulations
Cochrane Collaboration on Oral contraceptive formulations
Cost Effectiveness of Oral contraceptive formulations
Return to top

# Media Resources
Powerpoint Slides on Oral contraceptive formulations
Images of Oral contraceptive formulations
Podcasts & MP3s on Oral contraceptive formulations
Videos on Oral contraceptive formulations
Return to top

# Patient Resources
Patient Resources on Oral contraceptive formulations
Discussion Groups on Oral contraceptive formulations
Patient Handouts on Oral contraceptive formulations
Blogs on Oral contraceptive formulations
Oral contraceptive formulations in the News
Oral contraceptive formulations in the Marketplace
Return to top

# International Resources
Oral contraceptive formulations en Espanol
Return to top
Adapted from the FDA Package Insert.